Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Short term monotherapy with exenatide is superior to metformin in weight loss, improving insulin resistance and inflammation in chinese overweight/obese PCOS women
Accessed February 18, 2026
For patients who already established that their commercial plan wont cover a weight-loss GLP-1 or who are on government insurance and excluded from manufacturer savings cards the math is straightforward: Microdose GLP-1 Protocol at $129/mo, Semaglutide Injection at $189/mo, Tirzepatide Injection at $289/mo, or GLP-Squared at $289/mo all at or below branded self-pay maintenance rates, with Microdose and Semaglutide Injection priced below even the lowest-dose branded self-pay tiers
Diabetes Res Sci Technol
US$ 27.72
US$ 25.36
US$ 21.25
US$ 20.66
US$ 21.98
